Theoretical and Anti-Klebsiella pneumoniae Evaluations of Substituted 2,7-dimethylimidazo[1,2-a]pyridine-3-carboxamide and Imidazopyridine Hydrazide Derivatives
Molecules · 2023
DOI: 10.3390/molecules28062801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Suraj N Mali und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Ranchi 835215, India. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Anti-Infective Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research, Imam Mohammad Ibn Saud Islamic University (IMSIU), Saudi Arabia.
Abstract (Originalsprache)
A series of multistep synthesis protocols was adopted to synthesize substituted imidazopyridines (IMPs) (SM-IMP-01 to SM-IMP-13, and DA-01-05). All substituted IMPs were then characterized using standard spectroscopic techniques such as 1H-NMR, 13C-NMR, elemental analyses, and mass spectrometry. Our both in vitro qualitative and quantitative results for antibacterial analysis, against Klebsiella pneumoniae ATCC 4352 and Bacillus subtilis ATCC 6051 suggested that all compounds essentially exhibited activity against selected strains of bacteria. Our DFT analyses suggested that the compounds of the SM-IMP-01–SM-IMP-13 series have HOMO/LUMO gaps within 4.43–4.69 eV, whereas the compounds of the DA-01–DA-05 series have smaller values of the HOMO/LUMO gaps, 3.24–4.17 eV. The lowest value of the global hardness and the highest value of the global softness, 2.215 and 0.226 eV, respectively, characterize the compound SM-IMP-02; thus, it is the most reactive compound in the imidazopyridine carboxamide series (except hydrazide series). This compound also depicted lesser MIC values against Klebsiella pneumoniae ATCC 4352 and Bacillus subtilis ATCC 6051 as 4.8 µg/mL, each. In terms of another series, hydrazide DA-05 depicted strong antimicrobial actions (MIC: 4.8 µg/mL against both bacterial strains) and also had the lowest energy gap (3.24 eV), higher softness (0.309 eV), and lesser hardness (1.62 eV). Overall, when we compare qualitative and quantitative antimicrobial results, it is been very clear that compounds with dibromo substitutions on imidazopyridine (IMP) rings would act as better antimicrobial agents than those with -H at the eighth position on the IMP ring. Furthermore, substituents of higher electronegativities would tend to enhance the biological activities of dibromo-IMP compounds. DFT properties were also well comparable to this trend and overall, we can say that the electronic behavior of compounds under investigation has key roles in their bioactivities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Ranchi 835215, India.
- Department of Chemistry, Faculty of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.
- Department of Medicinal Chemistry and Drug Discovery, Dr. Rajendra Gode Institute of Pharmacy, University Mardi Road, Amravati 444603, India.
- Department of Chemistry, Universidad Técnica Federico Santa Maria, Santiago 7660251, Chile.
ORCID-Profile: Suraj N Mali, Magdi E A Zaki, Rahul D Jawarkar, Aleksey Kuznetsov
Förderung
- Deanship of Scientific Research, Imam Mohammad Ibn Saud Islamic University (IMSIU), Saudi Arabia
Zitieren
APA
Mali, S. N., Anand, A., Zaki, M. E. A., Al-Hussain, S. A., Jawarkar, R. D., Pandey, A., & Kuznetsov, A. (2023). Theoretical and Anti-Klebsiella pneumoniae Evaluations of Substituted 2,7-dimethylimidazo[1,2-a]pyridine-3-carboxamide and Imidazopyridine Hydrazide Derivatives. Molecules. https://doi.org/10.3390/molecules28062801
Vancouver
Mali SN, Anand A, Zaki MEA, Al-Hussain SA, Jawarkar RD, Pandey A, et al. Theoretical and Anti-Klebsiella pneumoniae Evaluations of Substituted 2,7-dimethylimidazo[1,2-a]pyridine-3-carboxamide and Imidazopyridine Hydrazide Derivatives. Molecules. 2023. doi:10.3390/molecules28062801
BibTeX
@article{Mali2023,
author = {Mali, Suraj N and Anand, Amit and Zaki, Magdi E A and Al-Hussain, Sami A and Jawarkar, Rahul D and Pandey, Anima and Kuznetsov, Aleksey},
title = {Theoretical and Anti-Klebsiella pneumoniae Evaluations of Substituted 2,7-dimethylimidazo[1,2-a]pyridine-3-carboxamide and Imidazopyridine Hydrazide Derivatives},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28062801}
}
EUVIMED